OncoMEDx, Inc.
Records under this name other than patents OncoMEDx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,767,390 | Methods for evaluating drug-resistance gene expression in the cancer patient Term ended Term ended Jul 27, 2024 · From the USPTO record | Term ended | Term ended Jul 27, 2024 | From the USPTO record |
| US 7,732,141 | Methods for evaluating drug-resistance gene expression in the cancer patient Lapsed on the fee record Ended Jun 8, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 8, 2022 | From the USPTO record |
| US 7,910,336 | Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum Term ended Term ended Jun 8, 2019 · From the USPTO record | Term ended | Term ended Jun 8, 2019 | From the USPTO record |
| US 8,163,524 | Comparative analysis of extracellular RNA species Term ended Term ended Dec 16, 2018 · From the USPTO record | Term ended | Term ended Dec 16, 2018 | From the USPTO record |
| US 7,932,061 | Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions Term ended Term ended Oct 16, 2018 · From the USPTO record | Term ended | Term ended Oct 16, 2018 | From the USPTO record |
| US 6,329,179 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Term ended Term ended Sep 22, 2018 · From the USPTO record | Term ended | Term ended Sep 22, 2018 | From the USPTO record |
| US 7,767,422 | Detection of 5T4 RNA in plasma and serum Lapsed on the fee record Ended Aug 3, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2018 | From the USPTO record |
| US 8,809,020 | Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma or serum to detect, monitor or evaluate cancer or premalignant conditions Term ended Term ended Jun 5, 2018 · From the USPTO record | Term ended | Term ended Jun 5, 2018 | From the USPTO record |
| US 7,785,842 | Comparative analysis of extracellular RNA species Term ended Term ended May 29, 2018 · From the USPTO record | Term ended | Term ended May 29, 2018 | From the USPTO record |
| US 7,709,233 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer Lapsed on the fee record Ended May 4, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2018 | From the USPTO record |